National Action Plan on AMR

Indian Economy glossary

Also called: NAP-AMR · Topic: Human Capital: Education, Health and Demographic Dividend · NCERT: Beyond NCERT

Meaning

The National Action Plan on AMR (NAP-AMR) is India's national policy to fight antimicrobial resistance, which is when germs change so that the medicines meant to kill them stop working. It follows a One Health approach: human, animal and environmental health are tackled together. The first plan came in 2017. A second version was released during World AMR Awareness Week 2025.

It matters because medicines that stop working damage health, and health is one of the two major sources of human capital. If common infections become hard to treat, workers fall sick more often and for longer, children miss school, and families spend more on treatment.

Explanation

What AMR is, and why economists care

  • Antimicrobials are medicines that kill or stop microbes (bacteria, viruses, fungi, parasites). Antibiotics are the best-known type.
  • Antimicrobial resistance (AMR) happens when microbes survive these medicines and pass on the ability to survive.
  • How resistance spreads (the note's sewage example):
  • antibiotic residues in sewage kill the sensitive bacteria;
  • the resistant ones survive and multiply;

  • mobile genetic elements (DNA pieces such as plasmids) carry the resistance genes to other bacteria.

  • AMR is a negative externality, meaning a cost that falls on people who did not cause it:

  • one person, farm or factory misuses an antibiotic;
  • resistance builds up in the shared environment;

  • everyone else then gets less benefit from that medicine.

  • This is the opposite of the external benefit in the study note. There, a healthy person who keeps up hygiene stops contagious diseases from spreading. Here, misuse spreads harm. In both cases markets get the amount wrong, because nobody pays for the effect on others. That is why the state has to act through a plan.

  • The human capital link:
  • health spending directly increases the supply of healthy labour;
  • a sick worker without effective treatment has to stay away from work, so output is lost;
  • if antibiotics fail, curative medicine (treatment during illness) becomes weaker. Preventive medicine and water and sanitation then matter even more.

The One Health approach

  • One Health means human, animal and environmental health are linked, so one sector cannot solve AMR by itself.
  • AMR moves across all three: hospitals, farms, sewage and public spaces.
  • Example: an IIT Madras study found that the microbes on Chennai Metro surfaces were shaped partly by nearby agricultural activity, as well as by coastal climate, humidity and urban density.
  • So the plan has to involve the health, animal husbandry, agriculture and environment departments together, not just hospitals.

Two levels: the national plan and State Action Plans

  • Public health and sanitation are in the State List (Seventh Schedule, Entry 6). The Centre sets the national plan, but States carry out most of the work.
  • So each State is expected to write its own State Action Plan on AMR.
  • Progress has been slow. Five years after the 2017 plan, only three States had one:
  • Kerala, October 2018 (KARSAP, the Kerala Antimicrobial Resistance Strategic Action Plan). It was the first.
  • Madhya Pradesh, July 2019.

  • Delhi, January 2020.

  • Tamil Nadu was not on the list. So a Chennai research finding had no State plan to feed into.

Surveillance: how the plan "sees" resistance

  • Surveillance means regularly watching for a disease threat. Under AMR it can mean testing patients, or testing the environment.
  • Environmental sampling methods:
  • Waste-water surveillance: sewage gathers waste from thousands of people across hospitals, homes and airports, so one sample gives a pooled picture. Indian urban sewage holds antibiotic residues, AMR genes and mobile genetic elements, which makes it a key AMR reservoir.

  • Surface swabbing: swabbing high-touch surfaces in public transport and reading all the DNA through whole-genome metagenomic sequencing.

  • Metagenomics is the direct genetic analysis of all the genomes in a sample. No lab culturing is needed.

  • WHO's view: wastewater and environmental surveillance (WES) is a promising complementary tool under One Health. But methods are not yet standardised, and there is limited evidence so far that its results lead to concrete public-health action.
  • Worked example of a data limit: the Chennai Metro study swabbed 96 samples, but only 47 passed quality control.
  • 47 ÷ 96 ≈ 0.49, so about 49% of the samples were usable.
  • Samples were taken in December 2021–January 2022, and the results became public in November 2026.
  • Lesson: data that is late or thin cannot give an early warning. The plan needs standard, regular and fast data.

What makes the plan succeed or fail

  • Helps: State Action Plans with a named office in charge; one national sampling standard; sewage and surface data from the same area at the same time; a route from research into government.
  • Hurts: States without plans; studies that have no link to government; samples from a single season; slow publication.

In India

  • The policy: National Action Plan on AMR (2017), built on One Health. Its second version was released during World AMR Awareness Week 2025.
  • Who acts: the Union Health Ministry (MoHFW) sets national health policy. States carry it out, because public health is a State subject (State List, Entry 6). ICMR handles biomedical research.
  • State plans: Kerala's KARSAP (2018) came first, followed by Madhya Pradesh (2019) and Delhi (2020). By 2022, these were the only three.
  • Data sources: Indian sewage studies, citywide waste-water resistome surveys, and the IIT Madras Chennai Metro "transit biome" study. The global comparison is MetaSUB, an international consortium with more than 3,700 samples from 58 cities. India has no matching national effort across its own cities.
  • The wider health system this sits in:
  • NHP 2017 targets public health spending of 2.5% of GDP (by 2025).
  • National Health Accounts 2021-22: government health spending is about 1.8% of GDP, and out-of-pocket spending (what families pay from their own pocket) is about 39% of total health spending.
  • High out-of-pocket costs make AMR worse for the poor. Resistant infections need longer and costlier treatment, which can push families into poverty.

Don't confuse with

  • Antimicrobial resistance (AMR): this is the problem (germs surviving medicines). NAP-AMR is the policy against it.
  • State Action Plan on AMR (e.g., KARSAP): written by a State, because public health is a State subject. NAP-AMR is the national plan. Kerala's 2018 plan was the first State plan, not the national one.
  • National Health Policy 2017: also from 2017, but it is India's overall health policy, with the 2.5%-of-GDP public spending target. NAP-AMR 2017 deals only with AMR.
  • WHO Wastewater and Environmental Surveillance guidance / MetaSUB: WHO's WES guidance is international technical advice, and MetaSUB is an international research consortium. Neither is an Indian government plan.

Prelims Hooks

  • NAP-AMR was first launched in 2017. Its second version was released during World AMR Awareness Week 2025.
  • NAP-AMR follows the One Health approach, which links human, animal and environmental health.
  • Kerala (KARSAP, October 2018) was the first State with its own AMR plan. Madhya Pradesh (July 2019) and Delhi (January 2020) followed. Five years after the national plan, only these three had one.
  • Public health and sanitation are in the State List, Entry 6, Seventh Schedule. That is why States need their own AMR plans.
  • Trap: "WHO treats environmental surveillance as a replacement for patient testing": FALSE. WHO calls it complementary, with methods not yet standardised.
  • Trap: "The Chennai Metro microbiome study was run under NAP-AMR by Chennai Metro Rail": FALSE. It was an IIT Madras research project. 96 swabs were taken and 47 were sequenced.

Mains Points

  • AMR as a market failure that hits human capital: antibiotic misuse is a negative externality, so the market will not limit it alone. NAP-AMR is the state's answer. Without effective medicines, curative care weakens, workers lose days to illness, and the demographic dividend loses its health base. With out-of-pocket spending at about 39% (NHA 2021-22), the poor carry the heaviest cost.
  • Federal gap: the Centre writes the plan, but States run public health. Only three State plans existed five years after 2017. Suggested fixes: a State plan for every State, a named nodal office in each, and Central funding tied to setting up surveillance.
  • Surveillance needs standards and speed: sewage and surface studies can act as population-level sentinels. But WHO notes that methods are not standardised, and studies such as Chennai's arrive years late, with only about half the samples usable. A national sampling protocol under NAP-AMR, repeated across seasons and cities, would turn scattered studies into a national early-warning system.

Read more